Evidence map›Paper›PMID 19855826›Full record

ReviewPLoS computational biology2009

The role of medical structural genomics in discovering new drugs for infectious diseases.

Wesley C Van Voorhis, Wim G J Hol, Peter J Myler, Lance J Stewart

Abstract readReview
In one paragraph

Review in PLoS computational biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Crystal structure of an inorganic pyrophosphatase from Chlamydia trachomatis D/UW-3/Cx.Acta crystallographica. Section F, Structural biology communications · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Structure of the prolyl-tRNA synthetase from the eukaryotic pathogen Giardia lamblia.Acta crystallographica. Section D, Biological crystallography · 2012
    Article
  8. Structural genomics of infectious disease drug targets: the SSGCID.Acta crystallographica. Section F, Structural biology and crystallization communications · 2011
    Article
  9. The Protein Maker: an automated system for high-throughput parallel purification.Acta crystallographica. Section F, Structural biology and crystallization communications · 2011
    Article
  10. Structures of a putative ζ-class glutathione S-transferase from the pathogenic fungus Coccidioides immitis.Acta crystallographica. Section F, Structural biology and crystallization communications · 2011
    Article
  11. Solution-state NMR structure and biophysical characterization of zinc-substituted rubredoxin B (Rv3250c) from Mycobacterium tuberculosis.Acta crystallographica. Section F, Structural biology and crystallization communications · 2011
    Article
  12. Microbial genomics and infectious diseases.The New England journal of medicine · 2011
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Unmet challenges of structural genomics.Current opinion in structural biology · 2010
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wesley C Van VoorhisDepartment of Medicine, University of Washington, Seattle, Washington, United States of America.
Wim G J Hol
Peter J Myler
Lance J Stewart

Funding

Target Selection and Ligand DiscoveryP01AI067921 · NIAID · UNIVERSITY OF WASHINGTON · PI HOL, WILHELMUS G. J. · 2006 to 2008
$6.7M
Glycogen Synthase Kinase-3 as a drug target for Trypanosoma bruceiR01AI080625 · NIAID · UNIVERSITY OF WASHINGTON · PI VAN VOORHIS, WESLEY C · 2009 to 2012
$1.5M
NIAID NIH HHS 1R01AI080625NIAID NIH HHS HHSN272200700057CNIAID NIH HHS P01 AI067921NIAID NIH HHS R01 AI080625PHS HHS HHSN266200700057C
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Infective AgentsChemistry, PharmaceuticalCommunicable DiseasesDatabases, ProteinDrug DesignGenomicsHumansModels, ChemicalModels, MolecularPharmacogeneticsSystems BiologyAnti-Infective Agents

Identifiers

PMID19855826
PMCPMC2756625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.